Optimal antithrombotic therapy after transcatheter aortic valve replacement in patients with atrial fibrillation

Atrial fibrillation (AF) is prevalent in patients with aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR). Depending on the timing of AF detection, it is usually categorized as pre-existing AF or new-onset AF. Antiplatelet therapy, rather than a vitamin K antagonist, may b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Qingchun, Cheng, Zhendong, Xia, Yi, Cheng, Rui, Ou, Ailian, Li, Xinrui, Xu, Xingbo, Huang, Yuli, Xu, Dingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576914/
https://www.ncbi.nlm.nih.gov/pubmed/33133475
http://dx.doi.org/10.1177/2040622320949068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576914/
https://www.ncbi.nlm.nih.gov/pubmed/33133475
http://dx.doi.org/10.1177/2040622320949068

Ejemplares similares